November 2018 the South China Morning Post reported that "US health care giant Johnson & Johnson is aggressively looking to invest further in manufacturing and research in China to strengthen efforts to localize medical innovations for new drugs that address the needs of one of its biggest markets, amid the ongoing trade war between the two countries."
The headline read "Johnson & Johnson still bullish on Chinese health care industry even as US-China trade war rages on. The company will open two new manufacturing plants with a combined investment of US$580 million in 2019." Fast forward to January 2020.
CNBC is reporting that "Johnson & Johnson’s chief scientific officer, Dr. Paul Stoffels, told CNBC on Monday that he believes the drugmaker can create a vaccine in the coming months to fight against the fast-spreading coronavirus. But he said it could take up to a year to bring it to market."
The Activist Post is reporting that "Prior to the coronavirus outbreak, The Johns Hopkins Center for Health Security hosted Event 201, a high-level pandemic exercise focused on a coronavirus outbreak — yes they ran a simulation of exactly what we see unfolding right now, before it happened! The pandemic exercise was conducted in partnership with the World Economic Forum and the Bill and Melinda Gates Foundation. During Event 201 Johnson & Johnson was asked specifically about a coronavirus vaccine."
"When asked, the Johnson & Johnson representative talked about the need for regulatory flexibility for an accelerated vaccine, financing and business. Not once did he mention safety or effectiveness. In today’s news, we see that Johnson & Johnson are currently working on a vaccine and they’re pretty confident they can quickly develop one." Things that make ya go hmmmm. Today the vaccine market is worth close to $24 billion.
No comments:
Post a Comment
Comments are moderated so there will be a delay before they appear on the blog.